Trialuminate
Matching Cancer Patients to Clinical Trials
Company Overview
Snapshot
Founded in January 2014 by Maytal Bivas-Benita, Trialuminate operates with 1–10 employees. The company has participated in one funding round and one non-equity funding event. In May 2017, Trialuminate completed a closing event.
Business overview
Trialuminate is a Health Tech & Life Sciences company focused on digital healthcare and patient engagement. The company develops a scientifically-based information platform that utilizes artificial intelligence and machine learning to biologically match cancer patients with clinical trials relevant to their specific condition. This web-based platform aims to educate, guide, and enable patients to make informed decisions about experimental treatments, serving both patients and healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- When was Trialuminate founded and by whom?
- Trialuminate was founded in January 2014 by Maytal Bivas-Benita.
- What is Trialuminate's primary focus?
- Trialuminate focuses on matching cancer patients to clinical trials using a scientifically-based information platform that leverages artificial intelligence and machine learning.
- What is the company's employee size?
- Trialuminate currently has 1–10 employees.
- What is Trialuminate's status as of May 2017?
- Trialuminate's status was Non Active as of May 2017.